Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (71-80 of 1,049) with videos related to

Pageof 105
Sort By:
Seminars in Arthritis and Rheumatism|November 20, 2015
Adult onset Still's disease associated with malignancy-Cause or coincidence?Katharina Hofheinz, Georg Schett, Bernhard Manger
Autoimmunity|May 23, 2007
The lonely death: chondrocyte apoptosis in TNF-induced arthritisKarin Polzer, Georg Schett, Jochen Zwerina
Trends in Molecular Medicine|May 13, 2008
Molecular mechanisms of inflammatory bone damage: emerging targets for therapySonja Herman, Gerhard Krönke, Georg Schett
Lancet (London, England)|September 25, 2023
CAR T-cell therapy in autoimmune diseasesGeorg Schett, Andreas Mackensen, Dimitrios Mougiakakos
Frontiers in Immunology|July 24, 2019
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid ArthritisUlrike Steffen, Georg Schett, Aline Bozec
Inflammation & Allergy Drug Targets|January 28, 2012
Inflammation-associated changes in bone homeostasisCarina Scholtysek, Gerhard Krönke, Georg Schett
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2019
Development of Joint Erosions in the Preclinical Phase of Rheumatoid Arthritis Depicted by Cinematic RenderingDavid Simon, Georg Schett, Arnd Kleyer
The New England Journal of Medicine|November 3, 2021
More on CD19-CAR T Cells in Systemic Lupus Erythematosus. ReplyDimitrios Mougiakakos, Gerhard Krönke, Georg Schett
Rheumatic Diseases Clinics of North America|October 23, 2012
Pathophysiology of new bone formation and ankylosis in spondyloarthritisRik J U Lories, Georg Schett
Current Rheumatology Reports|August 20, 2013
ACPA and bone loss in rheumatoid arthritisRoland Kocijan, Ulrike Harre, Georg Schett
Pageof 105

Showing results (71-80 of 1,049) with videos related to

Sort By:
Pageof 105
Seminars in Arthritis and Rheumatism|November 20, 2015
Adult onset Still's disease associated with malignancy-Cause or coincidence?Katharina Hofheinz, Georg Schett, Bernhard Manger
Autoimmunity|May 23, 2007
The lonely death: chondrocyte apoptosis in TNF-induced arthritisKarin Polzer, Georg Schett, Jochen Zwerina
Trends in Molecular Medicine|May 13, 2008
Molecular mechanisms of inflammatory bone damage: emerging targets for therapySonja Herman, Gerhard Krönke, Georg Schett
Lancet (London, England)|September 25, 2023
CAR T-cell therapy in autoimmune diseasesGeorg Schett, Andreas Mackensen, Dimitrios Mougiakakos
Frontiers in Immunology|July 24, 2019
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid ArthritisUlrike Steffen, Georg Schett, Aline Bozec
Inflammation & Allergy Drug Targets|January 28, 2012
Inflammation-associated changes in bone homeostasisCarina Scholtysek, Gerhard Krönke, Georg Schett
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2019
Development of Joint Erosions in the Preclinical Phase of Rheumatoid Arthritis Depicted by Cinematic RenderingDavid Simon, Georg Schett, Arnd Kleyer
The New England Journal of Medicine|November 3, 2021
More on CD19-CAR T Cells in Systemic Lupus Erythematosus. ReplyDimitrios Mougiakakos, Gerhard Krönke, Georg Schett
Rheumatic Diseases Clinics of North America|October 23, 2012
Pathophysiology of new bone formation and ankylosis in spondyloarthritisRik J U Lories, Georg Schett
Current Rheumatology Reports|August 20, 2013
ACPA and bone loss in rheumatoid arthritisRoland Kocijan, Ulrike Harre, Georg Schett
Pageof 105